Welcome to our dedicated page for Nutanix SEC filings (Ticker: NTNX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Nutanix builds a cloud platform so intricate that its SEC filings often stretch hundreds of pages across software revenue recognition tables, subscription renewal metrics, and stock-based pay plans. Finding where ARR growth is buried, or when executives sell shares before a major product release, shouldn’t consume your entire morning.
Stock Titan solves that problem. Our AI reads every Nutanix annual report 10-K simplified, each Nutanix quarterly earnings report 10-Q filing, and every Nutanix 8-K material events explained the moment they hit EDGAR. You’ll see
- real-time Nutanix Form 4 insider transactions real-time
- clear flags on Nutanix proxy statement executive compensation changes
- section-by-section Nutanix earnings report filing analysis
Curious about the sustainability of Nutanix’s subscription revenue? The AI-powered summaries spotlight deferred revenue roll-forwards and segment performance. Want alerts on Nutanix executive stock transactions Form 4 before the market reacts? We deliver them instantly. From growth investors tracking software margins to credit analysts watching cash burn, Stock Titan offers comprehensive coverage of every filing type, updated in real time and explained in language that turns complexity into clarity.
Insider Transaction Overview: Nutanix (NTNX) filed a Form 4 disclosing that President & CEO Rajiv Ramaswami sold 1,925 Class A common shares on 26 June 2025 at a reported price of $75 per share. The trade was executed automatically under a pre-arranged Rule 10b5-1 trading plan adopted 9 Sep 2024.
Post-Transaction Ownership: Following the sale, Ramaswami continues to hold 518,561 shares directly. The filing does not report any derivative transactions or changes to option positions.
Materiality Assessment: The divestiture is worth roughly $144,000, a de-minimis amount relative to the CEO’s remaining stake and Nutanix’s ~240 million shares outstanding. Because it was pre-scheduled, the transaction is generally viewed as routine and is unlikely to signal a shift in executive confidence.
Key Takeaways for Investors:
- Sale size represents less than 0.4% of the executive’s direct holdings.
- Use of a 10b5-1 plan limits potential concerns about timing or insider knowledge.
- No additional insider sales or option exercises were reported.
Nutanix, Inc. (NTNX) filed a Form 144 signaling a proposed insider sale by President & CEO Rajiv Ramaswami, who also serves as a director. The notice covers the potential disposition of 1,925 common shares—acquired as restricted stock on 15-Jun-2025—through Morgan Stanley Smith Barney, with an estimated market value of $144,375. The transaction is expected to occur on, or about, 26-Jun-2025 on the Nasdaq.
The filing discloses that approximately 268.1 million shares of Nutanix common stock are outstanding, so the size of the contemplated sale represents less than 0.001 % of shares outstanding and is therefore immaterial from a capitalization standpoint. Ramaswami adopted or amended a Rule 10b5-1 trading plan on 09-Sep-2024, which provides an affirmative defense against insider-trading allegations by automating trade execution.
Form 144 also lists recent insider activity: Ramaswami sold a total of 61,057 shares on 13-May-2025 for aggregate gross proceeds of roughly $4.82 million. Although insider sales do not automatically imply negative fundamentals, investors often track selling cadence to gauge executive sentiment. Given the minor size of the new sale and its compliance with a pre-arranged plan, the near-term market impact is likely negligible.